ArticleFrontiers in immunology2025

Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.

Mi-Ae Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.